Quantum-Si Q3 2023: $223k revenue, $24.7M net loss; controlled launch continues

Quantum-Si Inc

2023-Q3 EPS reported -$0.52 revenue$682,000

Revenue of $223,000; gross profit $108,000 (48% margin); net loss $24.7M vs. $31.7M YoY.
Adjusted EBITDA loss of $22.6M; adjusted operating expenses $23.9M.
Completed R&D strategic review; focused on delivering capabilities with highest customer demand.
First customer data presented; full commercial launch of Platinum instrument expected early 2024.
Appointed Amir Jafri as independent director, strengthening Board.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Quantum-Si Inc reported the third quarter ended September 30, 2023 results: revenue revenue of $223,000, net income Net loss was $24.7 million.

Period: the third quarter ended September 30, 2023
Revenue: revenue of $223,000
Net income: Net loss was $24.7 million
Result: reported results

Exact text from the filing

“Company”), The Protein Sequencing Company TM , today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights ● Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum instrument ● Completed a strategic review of

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Quantum-Si Inc filing history →

Source: SEC EDGAR

accession 0001140361-23-052467

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.